Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:07:58.278Z.
Calculation as of: 2026-10-06T19:07:58.278Z.
Quote observation: 2026-10-06T19:05:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e64ee45e162b8fcb3c04564696a4f5631675aa9d571ebc51c9b2157b48bafcf8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Rani Therapeutics Holdings, Inc.
Market Cap
$53.93M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.55M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.15M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.61M
Operating Cash Flow Yield
47.22%
TTM Avg
50.32%
3Y Avg
31.17%
5Y Avg
36.60%
Market Cap
$56.40M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $53.93M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | N/A | N/A | N/A | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $53.55M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $53.29M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.15M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.61M | 47.22% | 50.32% | 31.17% | 36.60% |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | N/A | N/A | N/A | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.40M | N/A | N/A | N/A | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
